NYU LANGONE HEALTH

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1841-01-01

Employees: 10K

Market Cap: -

Website: http://www.nyulangone.org

Clinical Trials

Patient Satisfaction With Virtual Postoperative Visit

Not Applicable

Completed

Conditions: Post-Op Complication

Interventions: Behavioral: Traditional
Behavioral: Virtual

First Posted Date: 2019-09-30

Last Posted Date: 2020-10-09

Lead Sponsor: NYU Langone Health

Target Recruit Count: 122

Registration Number: NCT04108442

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

Brain Plasticity Underlying Acquisition of New Organizational Skills in Children

Not Applicable

Completed

Conditions: Attention Deficit Hyperactivity Disorder
ADHD
Neurodevelopmental Disorders

Interventions: Behavioral: Organizational Skills Training

First Posted Date: 2019-09-30

Last Posted Date: 2024-08-01

Lead Sponsor: NYU Langone Health

Target Recruit Count: 59

Registration Number: NCT04108273

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

Blood Flow Restriction Therapy in Achilles Injury

Not Applicable

Recruiting

Conditions: Achilles Injuries Tendon

Interventions: Other: Blood flow restriction
Other: Standard of Care Physical Therapy

First Posted Date: 2019-09-26

Last Posted Date: 2024-07-31

Lead Sponsor: NYU Langone Health

Target Recruit Count: 47

Registration Number: NCT04104126

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

Study to Assess Feasibility and Safety of Iron Repletion With Feraheme in Iron Deficient Patients With Durable Ventricular Assist Device Support

Phase 4

Terminated

Conditions: Anemia

Interventions: Drug: Ferumoxytol injection

First Posted Date: 2019-09-06

Last Posted Date: 2023-07-18

Lead Sponsor: NYU Langone Health

Target Recruit Count: 1

Registration Number: NCT04080908

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

Heartmath Migraine Study

Not Applicable

Completed

Conditions: Migraine

Interventions: Behavioral: HeartMath
Behavioral: Waitlist Control

First Posted Date: 2019-09-04

Last Posted Date: 2020-08-24

Lead Sponsor: NYU Langone Health

Target Recruit Count: 52

Registration Number: NCT04077658

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

Vancomycin Powder and Dilute Povidone Iodine Lavage for Infection Prophylaxis in High Risk Total Joint Arthroplasty

Phase 1

Active, not recruiting

Conditions: Osteoarthritis

Interventions: Drug: Vancomycin powder
Drug: Povidone iodine
Other: Conventional

First Posted Date: 2019-08-30

Last Posted Date: 2024-03-04

Lead Sponsor: NYU Langone Health

Target Recruit Count: 2129

Registration Number: NCT04075526

Locations: 🇺🇸
Eisenhower Health, Rancho Mirage, California, United States
🇺🇸
Cleveland Clinic Florida, Weston, Florida, United States
🇺🇸
Rush University Medical Center, Chicago, Illinois, United States

and more 11 locations

Computer Aided Detection, Tandem Colonoscopy Study

Not Applicable

Completed

Conditions: Colonic Diseases

Interventions: Diagnostic Test: Standard technique First
Diagnostic Test: combination technique First

First Posted Date: 2019-08-30

Last Posted Date: 2021-06-29

Lead Sponsor: NYU Langone Health

Target Recruit Count: 32

Registration Number: NCT04074577

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

Clinical Reminder Changes to Increase Smoking Cessation Treatment in Outpatient Psychiatry

Not Applicable

Completed

Conditions: Smoking Cessation

Interventions: Behavioral: Opt-Out Reminder
Behavioral: Opt-In Reminder

First Posted Date: 2019-08-28

Last Posted Date: 2023-04-28

Lead Sponsor: NYU Langone Health

Target Recruit Count: 140

Registration Number: NCT04071795

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

Crutch Use After Arthroscopic Hip Surgery

Not Applicable

Completed

Conditions: Hip Injuries
Hip Fractures

Interventions: Other: 2 weeks of partial weight bearing on crutches
Other: 4 weeks of partial weight bearing on crutches

First Posted Date: 2019-08-28

Last Posted Date: 2021-07-29

Lead Sponsor: NYU Langone Health

Target Recruit Count: 50

Registration Number: NCT04070430

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

Dose Clinical Trial of Guanfacine Extended Release for the Reduction of Aggression and Self-injuries Behavior Associated With Prader-Willi Syndrome

Phase 4

Withdrawn

Conditions: Prader-Willi Syndrome

Interventions: Other: Placebo
Drug: Guanfacine extended release (GXR)

First Posted Date: 2019-08-26

Last Posted Date: 2020-08-26

Lead Sponsor: NYU Langone Health

Registration Number: NCT04066088

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy